US FDA's proposed reorganization of the Office of the Commissioner will elevate the agency’s medical product centers to report directly to Commissioner Scott Gottlieb, as part of a “flattening” of the org chart that he announced in an all-FDA email to staff this week.
The six center directors – including the Center for Devices and Radiological Health's Jeff Shuren – will report directly to Gottlieb, rather than a deputy commissioner as has been the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?